Clinical trial
Study to Evaluate the Immunogenicity and Safety of 2 Formulations of…
NCT00374842 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00374842 |
|---|---|
| Title | Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate |
| Official title | A Study to Evaluate the Immunogenicity, Safety and Reactogenicity of Adjuvanted Influenza Vaccine Candidates Compared to Fluarix™ Administered Intramuscularly in Subjects Aged 18-59 Years. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Fluarix™, GSK1247446A |
| Enrollment | 300 |
| Start date | Oct 3, 2006 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 30, 2006 |
| First posted | Sep 12, 2006 |
| Last update posted | Jun 8, 2018 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: